Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.7704
-0.0098 (-1.26%)
Feb 20, 2026, 1:05 PM EST - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $24.7 million as of February 20, 2026. Its market cap has decreased by -72.03% in one year.
Market Cap
24.70M
Enterprise Value
-9.98M
1-Year Change
-72.03%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $24.70M, a decrease of -93.06%. That is a compound annual growth rate of -76.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 25.00M | 4.17% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 27.11M |
| Barinthus Biotherapeutics | 26.95M |
| Lixte Biotechnology Holdings | 26.66M |
| Boundless Bio | 25.97M |
| Marker Therapeutics | 25.01M |
| IGC Pharma | 24.39M |
| Senti Biosciences | 24.19M |
| Neuphoria Therapeutics | 23.83M |